Stromal Gene Signatures in Large-B-Cell Lymphomas Nov 27, 2008
D., for the Lymphoma/Leukemia Molecular Profiling Project ... Background The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has significantly improved the survival of patients with diffuse large-B-cell lymphoma ... Whether gene-expression signatures correlate with survival after treatment of diffuse large-B-cell lymphoma is unclear. (New England Journal of Medicine)
Davis has no time to waste on pity party Nov 26, 2008
Diagnosed last spring with Hodgkin's lymphoma, Davis has come through chemotherapy without complaint and nears the end of his radiation treatments unlikely to avail himself of a medical hardship waiver that could extend his eligibility ... It's not that his prognosis is poor the five-year relative survival rate for Hodgkin's lymphoma exceeds 91 percent for those diagnosed before they turn 45 but the Aztecs are already strapped by the absence of Lorrenzo Wade. (San Diego Union-Tribune -- Sports)
3 Portland commissioners support expanded firefighter benefits Nov 26, 2008
Under the latest proposal, the following 12 forms of cancer would be assumed to be job-related when diagnosed in a firefighter: brain, colon, stomach, testicular, prostate, mouth, throat, breast, rectal, multiple myeloma, non-Hodgkin's lymphoma and leukemia ... They counter that medical studies found firefighting was a "probable" cause in only three of the cancers -- myeloma, non-Hodgkin's lymphoma and prostate. (OregonLive, OR -- News)
New Cases of Cancer Decline in the United States Nov 26, 2008
Rates of leukemia and non-Hodgkin s lymphoma increased in both sexes. The incidence of lung cancer has been declining among men for many years but rising among women, though the increase is slowing, according to the report. (Atlanta Journal-Constitution -- Health)
Accentia reorganization claims more jobs Nov 25, 2008
Accentia s drugs in development are BiovaxID, an anti-cancer vaccine focusing on treating non-Hodgkin s lymphoma and multiple myeloma; Revimmune, designed to treat multiple sclerosis and sickle cell anemia; and SinuNase, an intranasal treatment of chronic sinusitis. Sales of BiovaxID, made by the Biovest subsidiary, are expected to begin on a limited basis in Europe in January. (St. Louis Business Journal, MO)
Pennies for Patients Nov 21, 2008
All proceeds go to help children with leukemia and lymphoma. The school district's goal is to raise $2,000. (Kalona News, IA)
Over-stressing Already Taxed Cancer Cells May Kill Them Nov 20, 2008
His research team believes they can disrupt the over-stressed assembly line of mantle cell lymphoma and possibly similar cancers such as pancreatic, liver and breast, by taking away support needed for rapid protein turnover and by clogging up the mechanism for eliminating poorly made ones. Mantle cell lymphoma, an aggressive cancer of the lymphatic system that mostly occurs in middle age, responds initially to chemotherapy and antibiotics, but often returns, said Dr. Bhalla ... Much like a sink... (Science Daily)
Individuals With HIV Have Higher Risk Of Non-AIDS Cancers Nov 20, 2008
Although some cancers are known to be associated with HIV, such as Kaposi's sarcoma, non-Hodgkin's lymphoma and cervical cancer, limited research has been conducted on risk of non-AIDS cancers ... 8, 2005) In people infected with human immunodeficiency virus (HIV), highly active antiretroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new. (Science Daily)
• Stanley residents go bald for fire chief Nov 20, 2008
Andy Gunderson, the seven-year chief of the volunteer fire department of about 30, has Hodgkin Lymphoma, a cancer of the immune system ... Hodgkin Lymphoma has a survival rate estimated at 85 percent and afflicts about 156,172 people in the United States, according to the National Cancer Institute. (Burley South Idaho Press, ID)
Milo Payette Nov 20, 2008
He passed away at the Billings Clinic Hospital after a valiant battle with lymphoma surrounded by his loving family. Milo is survived by his loving wife of 47 years, Charlotte, Fairview; his two daughters, Natalie (Tim) Carson, Billings, and Valerie (Tony) Nolan, Belgrade, Mont. (Williston Daily Herald, ND)
Kiss and Grey Cup Nov 19, 2008
" Kontolemos was diagnosed with B-cell lymphoma, a non-Hodgkins cancer of the lymph nodes with a 50% to 60% cure rate. The treatments went well from the start, so that Calvillo was able to return for training camp in the spring with a clear mind and a new determination to win. The 36-year-old has flourished under new coach Marc Trestman's unpredictable offence and likely would have led the league in passing yards had he not been rested for the final regular season game after Montreal had already... (Toronto Sun)
Area marrow drive seeks donors Nov 18, 2008
The women are working with the National Marrow Donor Program of Philadelphia two weekends in a row to help find donor matches for patients suffering from conditions such as leukemia and lymphoma. A drive will be held Sunday, Nov. 23, at the Conference Center at Green Valley Country Club in Lafayette Hill from 10 a.m. to 1 p.m. and another will be held Saturday, Nov. 29, at the Ambler Area YMCA in Ambler from 9 a.m. to 11:30 a.m. Chair of "Jill's Journey for the Gift of Life" Jill Goldwater said... (Springfield Sun, PA)
Dermatology office to open in Easton on Dec. 8 Nov 18, 2008
The new capabilities will include narrow band UVB phototherapy for people with psoriasis, eczema and cutaneous T-cell lymphoma, hand and foot phototherapy for patients with resistant psoriasis or eczema of the extremities and blue light therapy for the treatment of pre-cancerous skin lesions. In addition, the practice will add new laser treatment programs for people with medical and cosmetic dermatology concerns and expand its popular array of cosmetic dermatology products and procedures. (Easton Journal, MA)
Tackling A Hard-to-treat Childhood Cancer By Targeting Epigenetic Changes Nov 18, 2008
Armstrong notes that there are already drugs in clinic that target enzymes that modify histones, namely histone deacetylase (HDAC) inhibitors, which are used to treat a kind of lymphoma and are being tested in other cancers. The study was funded by the National Cancer Institute, the Leukemia & Lymphoma Society, and the Damon Runyon Cancer Research Foundation. (Science Daily)
Manske respected, dedicated deputy Nov 18, 2008
He was originally diagnosed with T-cell lymphoma and underwent radiation treatment more than 21 years ago. About 10 years later he was again diagnosed with cancer Hodgkins disease in his nasal passage and underwent more radiation. (Wahpeton Daily News, ND)
Accentia subsidiaries seek to block lease Nov 18, 2008
AutovaxID produces an automated vaccine manufacturing instrument used in conjunction with Biovax, which has been developing an anti-cancer vaccine focused on treating non-Hodgkin s lymphoma and multiple myeloma. Both companies leased the space at 1701 Macklind Ave.; Biovest leases 17,000 square feet in Worcester, Mass. (St. Louis Business Journal, MO)
Rotary on track Nov 18, 2008
NON-HODGKINS Lymphoma survivor Ian Vei. STEVE Vallve and his dog Sasha are partn. (Footscray, Yarraville, Braybrook Star)
Carnival previews Thon Nov 17, 2008
Her son, Nick, 9, has a type of lymphoma cancer, and the family has been a part of Thon for three years. "It's so great to be able to see col- lege kids being so unselfish and giving so generously," she said. (Daily Collegian, PA)
Young cancer survivors start support group Nov 17, 2008
In June of 2007, LaBrune was diagnosed with Hodgkin's lymphoma. In need of someone to provide answers to her growing list of cancer questions, LaBrune was given the name of a fellow Hodgkin's lymphoma cancer survivor who had just finished her treatment. (Sioux City Journal, IO)
Support groups Nov 17, 2008
- Family Support Group for leukemia, lymphoma, Hodgkin's disease or myeloma, meets last Wednesday, from 6:30 to 8 p.m., Regional Cancer Center, 2500 W. 12th St. Call 464-9437. - Family and Caregiver Support Group meets second Monday of each month, from 6:30 to 7:30 p.m., Regional Cancer Center, 2500 W. 12th St. For family and caregivers of those with cancer or blood disorders. (Erie Times-News, PA)
New Treatment Method For Canine Eye Diseases Developed Nov 16, 2008
3, 2008) Dogs suffering from lymphoma will be able to receive the same type of medical treatment as their human counterparts, as North Carolina State University becomes the first university in the nation to. (Jan. (Science Daily)
Alamo Bowl suffers big loss Nov 15, 2008
Bowl officials say Brincat had been battling a recurrence of lymphoma and died from complications arising from the illness. He was a native of Michigan and a graduate of Wayne State University. (San Antonio Business Journal, TX)
Events raise funds for cancer patient Nov 15, 2008
After all, she said, her mother confounded doctors when she recovered from Stage 4 lymphoma eight years ago. "I don't know what I'm supposed to do besides fight like hell for my family and for myself," she said. (AZCentral -- News)
Stricken chow looks to NCSU Nov 15, 2008
Tina, who has lymphoma, arrives in Raleigh from Melbourne, Fla ... Otworth said that even the vets where he lives seemed excited that one day they might be able to offer all owners of dogs with lymphoma at least a hope of cure. (News & Observer)
The Leukemia & Lymphoma Society Congratulates Cy Young Award Winner Cliff Lee Nov 14, 2008
For the past three years, he and his wife, Kristen, have served as honorary chairs for The Leukemia & Lymphoma Society's (LLS) Northern Ohio Chapter Light The Night(TM) Walk ... About the Leukemia & Lymphoma Society ... The Leukemia & Lymphoma Society, headquartered in White Plains, NY, with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. (PR Newswire)
AIDS patient is reported cured Nov 14, 2008
In one case, a patient with both AIDS and lymphoma died of the cancer two months later, but was found to harbor no HIV; it was not known if something in the transplant had protected him. And in a famous 1995 case, Jeff Getty, a prominent San Francisco advocate for AIDS patients, received bone marrow from a baboon, which is resistant to the human virus. (International Herald Tribune)
Cal Travels to Florida for NCAA Tournament Nov 14, 2008
LaFontaine-Kussmann Returns to the Field Redshirt freshman returned to the field this season after being diagnosed with lymphoma last October. She was declared cancer free in the spring and is one of three veteran goalkeepers on this year's team. (Calbears.com)
Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloitte's 2008 Technology Fast 500 Nov 13, 2008
Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma ... Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma. (PR Newswire)
Cancer society turns sights to farm pesticides Nov 13, 2008
They contend that Health Canada and industry play down research linking occupational exposures to bug and weed sprays to greater risks of many cancers, such as non-Hodgkin's lymphoma ... For instance, U.S. researchers, publishing in the journal Blood in 2006, found that farmers who use a lot of pesticides and developed non-Hodgkin's lymphoma were 2. (Globe and Mail)
Yoga gains respect among doctors Nov 13, 2008
"We had breast cancer survivors, lymphoma survivors. Over the course of time -- three or four months -- I could see a lot more flexibility," he said, noting that patients also said they felt less stressed. About three years ago, Inzerillo began practicing what he had been teaching and scaled back. (News & Observer)
Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint Nov 11, 2008
5 Fold Higher Compared to Standard Chemotherapy SEATTLE, Nov. 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it achieved the primary efficacy endpoint of its phase III EXTEND (PIX301) trial of pixantrone (BBR2778) for patients with advanced, relapsed aggressive non-Hodgkin's lymphoma (NHL) based on a preliminary intent to treat efficacy analysis ... "These data are consistent with the extensive experience with pixantrone in our phase I and... (PR Newswire)
Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkin's Lymphoma Nov 10, 2008
SEATTLE, Nov. 10 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that Clinical Cancer Research has published in the November 1, 2008 issue the results of a study authored by Samual Jacobs et al. investigating the use of short-course CHOP-R followed by Zevalin ([90Y]-ibritumomab tiuxetan) and extended rituximab as first-line treatment in follicular non-Hodgkin's lymphoma patients ... "This study adds to recently published First-line Indolent Trial... (PR Newswire)
XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122 Nov 10, 2008
The investigational drug is in a Phase 1/B-2A clinical trial for the treatment of lymphoma and a Phase 1 clinical trial for the treatment of multiple myeloma. The antibody has a dual mechanism of action that involves inhibition of CD40-ligand mediated growth and survival while recruiting immune effector cells to kill CD40-expressing tumor cells through a process known as antibody-dependent cellular cytotoxicity (ADCC). (Primezone Releases)
After 40 years and 5000 transplants, a U celebration Nov 10, 2008
It can claim a long line of firsts, including: the first successful marrow transplant in a patient with lymphoma, in 1975; the first marrow transplant for an inherited metabolic disease, in 1982; Erik's cord transplant in 1994; and as recently as last year, a marrow transplant to cure a deadly skin disease -- the first use of marrow for an illness other than blood or bone marrow disorders ... Dr. John Kersey, who made the 1975 breakthrough on lymphoma treatment, said new methods in testing donor... (Minneapolis Star Tribune)
Toxins in Food Are Killing People Nov 9, 2008
Studies that Dr. Blaylock refers to show that leukemia and lymphoma increase with exposure to aspartame, as do breast cancer and brain cancers. In addition, aspartame is a proven addictive substance. (Suite101.com)
Time to punch up image Nov 9, 2008
e. adviser) in Chicago, left Detroit after 15 great years last summer, first and foremost to work with his son, Stan, the Blackhawks assistant general manager, who in recent years has waged a brave battle against Hodgkins lymphoma (now in remission). Scotty lives in Sarasota in the winter (suburban Buffalo in the summer), scouts NHL clubs that come through Tampa, and stays in constant contact with Stan. (Boston Globe -- Sports)
A Doctor, a Mutation and a Potential Cure for AIDS Nov 8, 2008
While scientists are drawing up research protocols to try this approach on other leukemia and lymphoma patients, they know it will never be widely used to treat AIDS because of the mortality risk ... A 41-year-old patient with AIDS and lymphoma underwent radiation and drug therapy to ablate his bone marrow and received new cells from a donor. (Wall Street Journal)
Stem-cell freezer malfunctions at Eastern Health Nov 8, 2008
The freezer was used to store stem cells for patients with blood cancers such as lymphoma and multiple myeloma. The freezer, and its backup that also failed, are designed to store stem cells at 150 C, according to Louise Jones, interim president and CEO of Eastern Health. (CBC.ca)
Novel Leukemia Vaccine For High-risk Patients In Clinical Trials Nov 8, 2008
Castro said that ISF35 also has the "potential to treat a range of blood cancers including lymphomas and even certain types of breast and lung cancers and melanoma," adding that future clinical trials are being planned. This trial is sponsored by Memgen, LLC, which is headquartered in Dallas, TX, and is funded by Memgen and the Leukemia & Lymphoma Society Therapy Acceleration Program. (Science Daily)
Cell Therapeutics Net Loss Declines as Operating Expenses Decrease By 58% in Third Quarter 2008 Nov 7, 2008
"We continue to make significant progress on the commercial front with the submission for a label expansion of Zevalin in September and our plan to report top-line results from the pixantrone pivotal trial in November, which if positive, would lead to us submitting an NDA in 2009," said James A. Bianco, M.D., CEO of CTI. "Importantly, we have made this progress while keeping in line with our strategy of reducing our expenses. Our net cash used for operating activities in the third quarter... (PR Newswire)
Thermogenesis losses grow amid recall Nov 7, 2008
Stem cells are used to treat cancers such as leukemia and lymphoma and blood diseases. The first quarter financial results include a $520,000 cost resulting from a voluntary recall of disposable AutoXpress stem-cell processing bags. (Sacramento Business Journal, CA)
UC Davis researchers discover Achilles' heel in pancreatic cancer Nov 7, 2008
Metabolic interruptions like this one are also being studied for their potential in treating cancers of the blood, such as leukemia and lymphoma. In those cases, depleting the amino acid asparagine may be used in slowing cancer-cell growth. (EurekAlert!)
Steven P. Bellomy Nov 6, 2008
In lieu of flowers, donations may be made in his name to The Leukemia and Lymphoma Society, The Louisiana Chapter, 3636 South I-10 Service Road, Suite 304, Metairie, LA 70001. To view online obituary, video tribute and sign the guest register, please visit. (New Iberia, LA)
Breast Implants Linked to Rare Cancer Nov 5, 2008
The results of a new study suggest that silicone breast prostheses may increase the risk of developing a rare form of lymphoma - cancer of the lymph system. However, the authors emphasize that because anaplastic large T-cell lymphoma (ALCL) of the breast is so rare, the absolute risk is still very low ... Each patient was matched by age and year of diagnosis to one or more women with other types of lymphomas in the breast (the control group). (Newsmax)
Newsweek: How we should fix biomedical research Nov 4, 2008
Rituxan for example is a blockbuster chemo drug that added 15% to the cure rate for large b-cell lymphoma, the most common type. It's made billions for Genentech. (MSNBC -- Health)
More of this story Nov 4, 2008
Alkire was diagnosed in 1999 with non-Hodgkin s lymphoma. She has been cancer-free for eight years. (Newport Daily News, RI)
Liver transplant recipients have higher cancer risk Nov 4, 2008
A new Canadian study comparing cancer rates of liver transplant patients to those of the general population has found that transplant recipients face increased risks of developing cancer, especially non-Hodgkin's lymphoma and colorectal cancer ... "A striking finding in our study is the approximate twenty-fold increased risk of non-Hodgkin's lymphoma among liver transplant patients relative to the general population," the authors report. (EurekAlert!)
Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial Nov 3, 2008
Novartis notified of data set closing, Top-line results expected in November SEATTLE, Nov. 3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it has closed the data set for preliminary analysis of the primary endpoint in the phase III EXTEND (PIX301) trial of pixantrone (BBR2278) for patients with relapsed diffuse large B cell non-Hodgkin's lymphoma (NHL) and it has provided Novartis notice that the data set has been closed ... About the EXTEND... (PR Newswire)
Rigel Announces Third Quarter 2008 Financial Results and Clinical Update Nov 3, 2008
Rigel expects to initiate a Phase 2 clinical trial for T-cell lymphoma within the next several months. The ongoing Phase 2 lymphoma clinical trial is continuing and is focused on diffuse large B-cell, follicular and other B- cell lymphomas, including chronic lymphocytic leukaemia and small lymphocytic lymphoma (CLL/SLL). (PR Newswire)
Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma Nov 1, 2008
Oct. 31 /PRNewswire-FirstCall/ -- Cephalon, Inc., (Nasdaq: CEPH) today announced that the U.S. Food and Drug Administration (FDA) has approved TREANDA(R) (bendamustine hydrochloride) for Injection for the treatment of patients with indolent B-cell non-Hodgkin's lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen ... Indolent NHL, a subset of non-Hodgkin's lymphoma, is a slow growing but serious cancer of the lymphatic... (PR Newswire)
Commerce reports drop in spending, income Nov 1, 2008
Cephalon Inc. received federal approval to sell its chemotherapy drug Treanda for treatment of patients with a type of non-Hodgkin's lymphoma ... The latest approval applies to Treanda for the treatment of patients with indolent B-cell non-Hodgkin's lymphoma that has progressed despite treatment with Rituxan or a regimen containing Rituxan. (San Diego Union-Tribune -- Business)
Genentech profit rises, sales top estimates Oct 31, 2008
U.S. sales of Rituxan for non-Hodgkin's lymphoma and rheumatoid arthritis jumped 15 percent to 655 million, exceeding analysts' expectations of 648 million ... non-Hodgkin's lymphoma. (Yahoo News -- Pharmaceutical Industry News)
Artificial Pancreas Could Revolutionize Treatment Of Type 1 Diabetes Oct 31, 2008
16, 2006) A drug used to treat lymphoma, rheumatoid arthritis and other immune disorders may enable newly-diagnosed type 1 diabetics to save some of their pancreas function and thereby reduce their. (Apr. (Science Daily)
Biovest plans cancer drug sales in Europe Oct 30, 2008
BiovaxID will be made available to patients suffering from various B-cell related blood cancers including chronic lymphocytic leukemia, mantle cell lymphoma, multiple myeloma and non-Hodgkin s lymphoma, the release said. Biovest said its distribution agreement is with IDIS Limited, a company headquartered in the United Kingdom that specializes in sourcing and supplying medicines on a named-patient basis to European hospitals, pharmacies, physicians and patients. (Tampa Bay Business Journal, FL)
Clean bill of health: Kevin Feeley survived cancer, but the bills are piling up Oct 30, 2008
That PET scan was the test which revealed his body is clear of cancer after a long battle with non-Hodgkin's lymphoma over the last year ... "I can't say enough about her. She kept saying 'I know it's the lymphoma. I know it's the lymphoma.'" ... The baby's cord blood is on hold for Kevin in case he needs it if his lymphoma returns. (Ames Daily Tribune, IA)
Northeast Baptist joins Texas Cord Blood Bank network Oct 29, 2008
Blood from the umbilical cord is rich in blood-making cells that can be used to help patients with a number of conditions, including bone-marrow transplants, people with lymphoma and leukemia, sickle-cell anemia and severe immune-system disorders. Our dreams are becoming reality, says Norman D. Kalmin, president, CEO and medical director of the. (San Antonio Business Journal, TX)
Novel Genetic Screens Provide Panoramic Views Of Cellular Systems Oct 29, 2008
This study is funded by Howard Hughes Medical Institute, Genome Canada, the European Union, and the Leukemia and Lymphoma Society. The authors report no conflicts of interest. (Science Daily)
Etanercept, Methotrexate Safe for Juvenile Rheumatoid Arthritis Oct 29, 2008
There were no cases of lymphoma, malignancy, tuberculosis or death. "Determining the safety of these agents was the primary goal; serious adverse events and medically important infections were prospectively and systematically collected in 594 patients representing over 1,200 years of exposure," researcher Dr. Norman T. Ilowite, chief of the division of rheumatology, Children's Hospital at Montefiore, and professor of pediatrics at the Albert Einstein College of Medicine in the Bronx, said in an... (MEDLINEplus)
Toreros Getting Involved in the Community Oct 29, 2008
Funds raised through Light The Night Walks support the work of hundreds of the world's best and brightest researchers in their search for better therapies and cures for leukemia, lymphoma, and myeloma. Our own , a survivor of Leukemia, was an Honored Hero for this event. (Usdtoreros.com)
Diagnosing The Health Care Debate Oct 27, 2008
Last year she was diagnosed with an aggressive type of cancer, follicular lymphoma. "You never think that something like this is going to happen," she said. (CBS News)
The right formula: Aquinas teacher makes math more meaningful Oct 27, 2008
But more than that, Born said Ring tutored her in calculus and other classes when she went through two years of chemotherapy for lymphoma. Mrs. Ring was adamant that my health was more important than any calculus theorem, Born said. (La Crosse Tribune, WI)
Business Briefs: Hospital garners two awards for services Oct 26, 2008
com The Leukemia and Lymphoma Society recently honored Athens Regional Medical Center and its Loran Smith Center for Cancer Support with the society;s Chairman;s Citation Award ... The Leukemia and Lymphoma Society recently honored Athens Regional Medical Center and its Loran Smith Center for Cancer Support with the society s Chairman s Citation Award. (Athens Banner-Herald)
Arthritis drugs do not raise cancer Oct 26, 2008
The drugs, known as TNF blockers, suppress the immune system by blocking the activity of an inflammatory protein called tumor necrosis factor, or TNF. They have been used since 1998, but some studies have suggested the drugs raise the risk of cancer, particularly lung cancer and lymphoma - by toning down the immune system. "Despite foreseen fears, blocking the tumor necrosis factor does not make patients more prone to develop cancer," Dr. Loreto Carmona of the Fundacion Espanola de Reumatologia... (India Times, India)
Saints soccer set to Help Carroll Kick Cancer’ Oct 25, 2008
It was roughly this time last year that he found out her form of lymphoma had returned more aggressive than ever ... Carroll College s sports department has had its battles with the disease, from players like junior offensive guard Luke Den Herder s recovery from non-Hodgkins Burkitt s Lymphoma, to its faculty and staff s own treatments. (Helena Independent Record, MT)
USD coach to celebrate victory over leukemia Oct 25, 2008
The Light The Night event, part of a nationwide Leukemia & Lymphoma Society program, celebrates and commemorates people who have been touched by cancer. Hagedorn, 43, will carry an illuminated white balloon, signifying himself as a cancer survivor. (San Diego Union-Tribune -- Sports)
